Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML
暂无分享,去创建一个
D. Couriel | R. Champlin | K. Komanduri | S. Giralt | G. Rondón | B. Oran | M. Lima | R. Saliba | P. Patah | J. D. Souza | S. Giralt | D. Couriel | G. Rondon
[1] P. Thall,et al. Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome , 2008, Leukemia.
[2] E. Shpall,et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. , 2007, Blood.
[3] U. Popat,et al. Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[4] J. Schulte‐Mönting,et al. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients , 2007, Bone Marrow Transplantation.
[5] K. Rezvani,et al. Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. , 2006, Blood.
[6] D. Gilliland,et al. Drug therapy for acute myeloid leukemia. , 2005, Blood.
[7] M. Munsell,et al. Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation. , 2004, Blood.
[8] S. Sohn,et al. Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation , 2004, British journal of haematology.
[9] L. Rybicki,et al. Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant , 2004, Bone Marrow Transplantation.
[10] E. Estey,et al. Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years. , 2003, Blood.
[11] Santhosh K. P. Kumar,et al. Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia , 2003, Leukemia.
[12] D. Marks,et al. Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback , 2003, Bone Marrow Transplantation.
[13] Shaji K. Kumar,et al. Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia , 2001, Bone Marrow Transplantation.
[14] A. Hagemeijer,et al. Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. , 2001, Blood.
[15] R. Storb,et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. , 2001, Blood.
[16] F. Frassoni,et al. Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft‐versus‐host disease, donor type, cytomegalovirus infections and cell dose , 2001, British journal of haematology.
[17] S. Singhal,et al. Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation. , 1998, Blood.
[18] J. Armitage,et al. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] F. Appelbaum,et al. The Problem of Thrombocytopenia after Hematopoietic Stem Cell Transplantation , 1996, The oncologist.
[20] T. D. de Witte,et al. Clonal predominance of cytomegalovirus-specific CD8+ cytotoxic T lymphocytes in bone marrow recipients. , 1996, Bone marrow transplantation.
[21] H. Einsele,et al. Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. , 1993, Blood.
[22] N. Lee,et al. Prognostic significance of platelet recovery pattern after allogeneic HLA-identical sibling transplantation and its association with severe acute GVHD , 2006, Bone Marrow Transplantation.